153 related articles for article (PubMed ID: 36058861)
1. [Clinical significance of detecting human leukocyte antigen class I allele-lacking leukocytes in aplastic anemia].
Hosokawa K; Nakao S
Rinsho Ketsueki; 2022; 63(8):899-905. PubMed ID: 36058861
[TBL] [Abstract][Full Text] [Related]
2. [A loss-of-function mutation in exon1 of limited HLA class I alleles is common in patients with aplastic anemia].
Mizumaki H
Rinsho Ketsueki; 2021; 62(4):270-277. PubMed ID: 33967152
[TBL] [Abstract][Full Text] [Related]
3. [Immune pathophysiology of bone marrow failure].
Hosokawa K
Rinsho Ketsueki; 2023; 64(9):908-915. PubMed ID: 37793865
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
Maciejewski JP; Follmann D; Nakamura R; Saunthararajah Y; Rivera CE; Simonis T; Brown KE; Barrett JA; Young NS
Blood; 2001 Dec; 98(13):3513-9. PubMed ID: 11739151
[TBL] [Abstract][Full Text] [Related]
5. The frequency of HLA class I alleles in Japanese patients with bone marrow failure.
Shichishima T; Noji H; Ikeda K; Akutsu K; Maruyama Y
Haematologica; 2006 Jun; 91(6):856-7. PubMed ID: 16704965
[TBL] [Abstract][Full Text] [Related]
6. HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria.
Shichishima T; Okamoto M; Ikeda K; Kaneshige T; Sugiyama H; Terasawa T; Osumi K; Maruyama Y
Blood; 2002 Jul; 100(1):22-8. PubMed ID: 12070003
[TBL] [Abstract][Full Text] [Related]
7. A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemia.
Mizumaki H; Hosomichi K; Hosokawa K; Yoroidaka T; Imi T; Zaimoku Y; Katagiri T; Anh Thi Nguyen M; Cao Tran D; Ibrahim Yousef Elbadry M; Chonabayashi K; Yoshida Y; Takamatsu H; Ozawa T; Azuma F; Kishi H; Fujii Y; Ogawa S; Tajima A; Nakao S
Haematologica; 2021 Jun; 106(6):1581-1590. PubMed ID: 32439725
[TBL] [Abstract][Full Text] [Related]
8. N-RAS gene mutation in patients with aplastic anemia and aplastic anemia/ paroxysmal nocturnal hemoglobinuria during evolution to clonal disease.
Mortazavi Y; Tooze JA; Gordon-Smith EC; Rutherford TR
Blood; 2000 Jan; 95(2):646-50. PubMed ID: 10627475
[TBL] [Abstract][Full Text] [Related]
9. Potential link between MHC-self-peptide presentation and hematopoiesis; the analysis of HLA-DR expression in CD34-positive cells and self-peptide presentation repertoires of MHC molecules associated with paroxysmal nocturnal hemoglobinuria.
Nowak J; Wozniak J; Mendek-Czajkowska E; Dlugokecka A; Mika-Witkowska R; Rogatko-Koros M; Graczyk-Pol E; Marosz-Rudnicka A; Dziopa J; Golec A; Kopec-Szlezak J; Warzocha K
Cell Biochem Biophys; 2013 Apr; 65(3):321-33. PubMed ID: 23076633
[TBL] [Abstract][Full Text] [Related]
10. HLA Class I Allele Loss and Bone Marrow Transplantation Outcomes in Immune Aplastic Anemia.
Zaimoku Y; Katagiri T; Nakagawa N; Imi T; Maruyama H; Takamatsu H; Ishiyama K; Yamazaki H; Miyamoto T; Nakao S
Transplant Cell Ther; 2024 Mar; 30(3):281.e1-281.e13. PubMed ID: 37972732
[TBL] [Abstract][Full Text] [Related]
11. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
12. [Acquired aplastic anemia].
Hosokawa K; Nakao S
Rinsho Ketsueki; 2019; 60(5):417-422. PubMed ID: 31168007
[TBL] [Abstract][Full Text] [Related]
13. Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.
Olson TS; Frost BF; Duke JL; Dribus M; Xie HM; Prudowsky ZD; Furutani E; Gudera J; Shah YB; Ferriola D; Dinou A; Pagkrati I; Kim S; Xu Y; He M; Zheng S; Nijim S; Lin P; Xu C; Nakano TA; Oved JH; Carreno BM; Bolon YT; Gadalla SM; Marsh SG; Paczesny S; Lee SJ; Monos DS; Shimamura A; Bertuch AA; Gragert L; Spellman SR; Babushok DV
JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36219480
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia.
Maruyama H; Katagiri T; Kashiwase K; Shiina T; Sato-Otsubo A; Zaimoku Y; Maruyama K; Hosokawa K; Ishiyama K; Yamazaki H; Inoko H; Ogawa S; Nakao S
Exp Hematol; 2016 Oct; 44(10):931-939.e3. PubMed ID: 27250585
[TBL] [Abstract][Full Text] [Related]
15. Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery?
Gurnari C; Pagliuca S; Maciejewski JP
Leuk Lymphoma; 2023; 64(8):1389-1399. PubMed ID: 37356012
[TBL] [Abstract][Full Text] [Related]
16. The patterns of MHC association in aplastic and non-aplastic paroxysmal nocturnal hemoglobinuria.
Nowak J; Mika-Witkowska R; Mendek-Czajkowska E; Rogatko-Koroś M; Graczyk-Pol E; Pyl H; Klimczak A; Wójcik M; Prochorec-Sobieszek M; Maryniak R; Zupańska B
Arch Immunol Ther Exp (Warsz); 2011 Jun; 59(3):231-8. PubMed ID: 21442308
[TBL] [Abstract][Full Text] [Related]
17. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Sun L; Babushok DV
Blood; 2020 Jul; 136(1):36-49. PubMed ID: 32430502
[TBL] [Abstract][Full Text] [Related]
18. Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia.
Chen L; Ge M; Huo J; Ren X; Shao Y; Li X; Huang J; Wang M; Nie N; Zhang J; Peng J; Zheng Y
Front Immunol; 2023; 14():1056381. PubMed ID: 36793734
[TBL] [Abstract][Full Text] [Related]
19. Killer immunoglobulin-like receptor genotype in immune-mediated bone marrow failure syndromes.
Howe EC; Wlodarski M; Ball EJ; Rybicki L; Maciejewski JP
Exp Hematol; 2005 Nov; 33(11):1357-62. PubMed ID: 16263420
[TBL] [Abstract][Full Text] [Related]
20. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
